Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne [Phase 4]
Phase 4 trial update on the efficacy of an oral probiotic combined with topical benzoyl peroxide and adapalene for acne vulgaris.
-
FDA approval · 2022-01-14FDA Approved: ADAPALENE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's generic adapalene in an original [ANDA] application for topical use to treat acne vulgaris. This marks…
-
FDA approval · 2022-01-13FDA Approved: AMZEEQ — Supplemental Application (Journey Medical Corporation)
FDA approved a supplemental application for AMZEEQ (minocycline) by Journey Medical Corporation. The action relates to the approval of a sup…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris [Phase 3]
Phase 3 trial update reporting participant-reported outcomes for trifarotene 50 μg/g cream in moderate facial and truncal acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: A Study of S6G5T-3 in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial in Acne Vulgaris has completed; results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: A Study of S6G5T3 in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial for S6G5T3 in acne vulgaris completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris [Phase 2]
A Phase 2 multicenter randomized trial in acne vulgaris has completed with results posted.
-
FDA approval · 2021-11-09FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for ZENATANE (isotretinoin) submitted by BluePoint Laboratories.
-
FDA approval · 2021-11-08FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc. This action updates the approval sta…
-
FDA approval · 2021-11-08FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) by Mylan Pharmaceuticals Inc.
-
FDA approval · 2021-11-08FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2021-11-08FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved a supplemental application for isotretinoin from Mayne Pharma, indicating an additional regulatory approval for this product un…
-
FDA approval · 2021-11-08FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for isotretinoin from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Afamelanotide in Patients Suffering With Acne Vulgaris [Phase 2]
Phase 2 clinical trial update for afamelanotide in acne vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne [Phase 4]
Phase 4 trial assessing the efficacy of a dermocosmetic product with fixed combination Adapalene 0.1% / Benzoyl Peroxide 2.5% vs standard mo…
-
FDA approval · 2021-10-08FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for isotretinoin from Actavis Pharma, Inc., resulting in changes to the product labeling under the A…
-
FDA approval · 2021-10-08FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2021-10-08FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals Inc., representing an approval of a …
-
FDA approval · 2021-10-08FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2021-10-08FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) filed by Sun Pharmaceutical Industries, Inc. The approval may involv…
-
FDA approval · 2021-10-08FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA LD (isotretinoin) submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2021-10-08FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for isotretinoin submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2021-10-08FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for isotretinoin by Upsher-Smith Laboratories, updating the product labeling.
-
FDA approval · 2021-10-08FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
The FDA has approved a supplemental application for isotretinoin submitted by Mayne Pharma.
-
FDA approval · 2021-10-08FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for isotretinoin by Amneal Pharmaceuticals NY LLC under an ANDA.